Bordeaux Population Health Research Center, Team LEHA, Unité Mixte de Recherche (UMR) 1219, INSERM, Université de Bordeaux, Bordeaux, France.
Bordeaux Population Health Research Center, Team LEHA, Unité Mixte de Recherche (UMR) 1219, INSERM, Université de Bordeaux, Bordeaux, France.
Ophthalmology. 2018 Aug;125(8):1149-1159. doi: 10.1016/j.ophtha.2018.02.005. Epub 2018 Mar 13.
To estimate the prevalence of nonrefractive visual impairment and blindness in European persons 55 years of age and older.
Few visual impairment and blindness prevalence estimates are available for the European population. In addition, many of the data collected in European population-based studies currently are unpublished and have not been included in previous estimates.
Fourteen European population-based studies participating in the European Eye Epidemiology Consortium (n = 70 723) were included. Each study provided nonrefractive visual impairment and blindness prevalence estimates stratified by age (10-year strata) and gender. Nonrefractive visual impairment and blindness were defined as best-corrected visual acuity worse than 20/60 and 20/400 in the better eye, respectively. Using random effects meta-analysis, prevalence rates were estimated according to age, gender, geographical area, and period (1991-2006 and 2007-2012). Because no data were available for Central and Eastern Europe, population projections for numbers of affected people were estimated using Eurostat population estimates for European high-income countries in 2000 and 2010.
The age-standardized prevalence of nonrefractive visual impairment in people 55 years of age or older decreased from 2.22% (95% confidence interval [CI], 1.34-3.10) from 1991 through 2006 to 0.92% (95% CI, 0.42-1.42) from 2007 through 2012. It strongly increased with age in both periods (up to 15.69% and 4.39% in participants 85 years of age or older from 1991 through 2006 and from 2007 through 2012, respectively). Age-standardized prevalence of visual impairment tended to be higher in women than men from 1991 through 2006 (2.67% vs. 1.88%), but not from 2007 through 2012 (0.87% vs. 0.88%). No differences were observed between northern, western, and southern regions of Europe. The projected numbers of affected older inhabitants in European high-income countries decreased from 2.5 million affected individuals in 2000 to 1.2 million in 2010. Of those, 584 000 were blind in 2000, in comparison with 170 000 who were blind in 2010.
Despite the increase in the European older population, our study indicated that the number of visually impaired people has decreased in European high-income countries in the last 20 years. This may be the result of major improvements in eye care and prevention, the decreasing prevalence of eye diseases, or both.
评估欧洲 55 岁及以上人群中非屈光性视力损害和盲的患病率。
目前,对于欧洲人口,视力损害和盲患病率的估计值很少。此外,欧洲人群为基础的研究中收集的许多数据目前尚未公布,并且尚未包含在以前的估计中。
纳入了参加欧洲眼流行病学联盟的 14 项欧洲人群为基础的研究(n=70723)。每个研究都根据年龄(每 10 年一个分层)和性别提供了非屈光性视力损害和盲的患病率估计值。非屈光性视力损害和盲分别定义为最佳矫正视力在较好眼中差于 20/60 和 20/400。使用随机效应荟萃分析,根据年龄、性别、地理区域和时期(1991-2006 年和 2007-2012 年)估计患病率。由于没有中欧和东欧的数据,因此使用 2000 年和 2010 年欧洲高收入国家的 Eurostat 人口估计值对受影响人数的人口预测进行了估计。
55 岁及以上人群中,年龄标准化的非屈光性视力损害患病率从 1991 年至 2006 年的 2.22%(95%置信区间[CI],1.34-3.10)下降到 2007 年至 2012 年的 0.92%(95% CI,0.42-1.42)。在这两个时期,患病率都随着年龄的增长而显著增加(在 2006 年至 85 岁及以上人群中,从 1991 年至 2006 年分别为 15.69%和 4.39%,从 2007 年至 2012 年分别为 4.39%和 4.39%)。在 1991 年至 2006 年期间,女性的视力损害患病率高于男性(2.67%比 1.88%),但在 2007 年至 2012 年期间则没有差异(0.87%比 0.88%)。在欧洲北部、西部和南部地区之间没有观察到差异。在欧洲高收入国家,受影响的老年居民人数从 2000 年的 250 万减少到 2010 年的 120 万。其中,2000 年有 58.4 万人失明,而 2010 年有 17 万人失明。
尽管欧洲老年人口有所增加,但我们的研究表明,在过去 20 年中,欧洲高收入国家视力受损的人数有所减少。这可能是眼部护理和预防的重大改善、眼部疾病患病率的下降或两者共同作用的结果。